Effect Of Pathyadi Kwatha In Dysfunctional Uterine Bleeding(Asrigdara)

A CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF PATHYADI KWATHA IN ASRIGDARA W.S.R. TO DYSFUNCTIONAL UTERINE BLEEDING - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058721

Enrollment

Registered

2023-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pratyatma lakshana of Asrigdara and DUB. Asrigdara-Artava deergha kala Pravritti, Artava Ati Pravritti, Anruta kala Pravritti.

Exclusion criteria

Exclusion criteria: 1.K/C/O – Diabetes mellitus, hypertension, tuberculosis. 2.Patient using intra uterine contraceptive device 3.K/C/O-Coagulation disorders 4.Patient with severe anemia HB% below 8 gms 5.K/C/O- Any pelvic pathology

Design outcomes

Primary

Measure	Time frame
Effect of trial drug on improvement in the symptoms of Asrigdara(DUB).Timepoint: 4th day of menses, 10th day for three consecutive cycle	—

Secondary

Measure	Time frame
Safety of the trial drug & Adverse Drug reaction & Aggravation in the symptoms of Asrigdara(DUB)Timepoint: 4th day of menses, 10th day for three consecutive cycle	—

Countries

India

Contacts

Public ContactDr Komal T Gayakwad

Sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre

chaitanya.rawal@gmail.com9880976151

Outcome results